{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:58:01Z","timestamp":1787237881350,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00259-025-07244-9","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T11:35:54Z","timestamp":1743852954000},"page":"3632-3642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Total or partial adrenalectomy for aldosterone-producing adenoma: can 68Ga-Pentixafor PET\/CT predict surgical outcomes?"],"prefix":"10.1007","volume":"52","author":[{"given":"Wen-Cai","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Renshun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Mei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou-Fei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Shui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Bin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-7025","authenticated-orcid":false,"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"issue":"22","key":"7244_CR1","doi-asserted-by":"publisher","first-page":"E773","DOI":"10.1503\/cmaj.161486","volume":"189","author":"GA Kline","year":"2017","unstructured":"Kline GA, Prebtani APH, Leung AA, Schiffrin EL. Primary aldosteronism: a common cause of resistant hypertension. CMAJ. 2017;189(22):E773\u20138.","journal-title":"CMAJ"},{"issue":"5","key":"7244_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7244_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertens (Dallas Tex: 1979). 2014;63(1):151\u201360.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"12","key":"7244_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9(12):876\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"7244_CR5","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J, et al. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur J Nucl Med Mol Imaging. 2020;47(11):2656\u201365.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7244_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.eururo.2018.07.030","volume":"75","author":"G Simone","year":"2019","unstructured":"Simone G, Anceschi U, Tuderti G, et al. Robot-assisted partial adrenalectomy for the treatment of Conn\u2019s syndrome: surgical technique, and perioperative and functional outcomes. Eur Urol. 2019;75(5):811\u20136.","journal-title":"Eur Urol"},{"issue":"5","key":"7244_CR7","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.juro.2010.12.051","volume":"185","author":"B Fu","year":"2011","unstructured":"Fu B, Zhang X, Wang GX, et al. Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2011;185(5):1578\u201382.","journal-title":"J Urol"},{"issue":"6","key":"7244_CR8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.euf.2020.06.023","volume":"7","author":"U Anceschi","year":"2021","unstructured":"Anceschi U, Tuderti G, Fiori C, et al. Minimally invasive partial versus total adrenalectomy for the treatment of primary aldosteronism: results of a multicenter series according to the PASO criteria. Eur Urol Focus. 2021;7(6):1418\u201323.","journal-title":"Eur Urol Focus"},{"issue":"Pt A","key":"7244_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijsu.2015.01.015","volume":"16","author":"V Nagaraja","year":"2015","unstructured":"Nagaraja V, Eslick GD, Edirimanne S. Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis. Int J Surg (London England). 2015;16(Pt A):7\u201313.","journal-title":"Int J Surg (London England)"},{"issue":"1","key":"7244_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","volume":"174","author":"S Ishidoya","year":"2005","unstructured":"Ishidoya S, Ito A, Sakai K, et al. Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2005;174(1):40\u20133.","journal-title":"J Urol"},{"issue":"5","key":"7244_CR11","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/HYPERTENSIONAHA.115.05993","volume":"66","author":"FL Fernandes-Rosa","year":"2015","unstructured":"Fernandes-Rosa FL, Giscos-Douriez I, Amar L, et al. Different somatic mutations in multinodular adrenals with Aldosterone-Producing adenoma. Hypertension. 2015;66(5):1014\u201322.","journal-title":"Hypertension"},{"key":"7244_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","volume":"411","author":"S Monticone","year":"2015","unstructured":"Monticone S, Castellano I, Versace K, et al. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Mol Cell Endocrinol. 2015;411:146\u201354.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"7244_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1210\/endrev\/bnad026","volume":"45","author":"N Mullen","year":"2024","unstructured":"Mullen N, Curneen J, Donlon PT, et al. Treating primary Aldosteronism-Induced hypertension: novel approaches and future outlooks. Endocr Rev. 2024;45(1):125\u201370.","journal-title":"Endocr Rev"},{"issue":"2","key":"7244_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P, et al. Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of Aldosterone-Producing adenoma. Hypertens (Dallas Tex: 1979). 2018;71(2):317\u201325.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"4","key":"7244_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.juro.2006.11.098","volume":"177","author":"X Zhang","year":"2007","unstructured":"Zhang X, Fu B, Lang B, et al. Technique of anatomical retroperitoneoscopic adrenalectomy with report of 800 cases. J Urol. 2007;177(4):1254\u20137.","journal-title":"J Urol"},{"issue":"9","key":"7244_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"7244_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Interval Estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17(8):873\u201390.","journal-title":"Stat Med"},{"issue":"1","key":"7244_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","volume":"29","author":"X Wu","year":"2023","unstructured":"Wu X, Senanayake R, Goodchild E, et al. [11\u00a0C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med. 2023;29(1):190\u2013202.","journal-title":"Nat Med"},{"issue":"1","key":"7244_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1210\/jc.2011-1537","volume":"97","author":"TJ Burton","year":"2012","unstructured":"Burton TJ, Mackenzie IS, Balan K, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas. J Clin Endocrinol Metab. 2012;97(1):100\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"7244_CR20","doi-asserted-by":"crossref","unstructured":"Gao Y, Ding J, Cui Y, et al. Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-pentixafor PET\/CT. Eur Radiol. 2022.","DOI":"10.1007\/s00330-022-09058-x"},{"issue":"2","key":"7244_CR21","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"Hu J, Xu T, Shen H, et al. Accuracy of Gallium-68 pentixafor positron emission tomography-Computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw Open. 2023;6(2):e2255609.","journal-title":"JAMA Netw Open"},{"issue":"1\u20132","key":"7244_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000501216","volume":"104","author":"M Balci","year":"2020","unstructured":"Balci M, Tuncel A, Aslan Y, Aykanat C, Berker D, Guzel O. Laparoscopic partial versus total adrenalectomy in nonhereditary unilateral adrenal masses. Urol Int. 2020;104(1\u20132):75\u201380.","journal-title":"Urol Int"},{"issue":"9","key":"7244_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1089\/end.2014.0102","volume":"28","author":"SF Chen","year":"2014","unstructured":"Chen SF, Chueh SC, Wang SM, et al. Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: partial versus total adrenalectomy. J Endourol. 2014;28(9):1103\u20136.","journal-title":"J Endourol"},{"issue":"6","key":"7244_CR24","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7244_CR25","first-page":"165","volume":"18","author":"N Simforoosh","year":"2020","unstructured":"Simforoosh N, Soltani MH, Shemshaki H, Bonakdar Hashemi M, Dadpour M, Kashi AH. Symptom resolution and recurrence outcomes after partial versus total laparoscopic adrenalectomy: 13 years of experience with Medium-Long term follow up. Urol J. 2020;18(2):165\u201370.","journal-title":"Urol J"},{"issue":"6","key":"7244_CR26","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0022-5347(01)67303-8","volume":"153","author":"T Nakada","year":"1995","unstructured":"Nakada T, Kubota Y, Sasagawa I, Yagisawa T, Watanabe M, Ishigooka M. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma. J Urol. 1995;153(6):1775\u201380.","journal-title":"J Urol"},{"issue":"7","key":"7244_CR27","doi-asserted-by":"publisher","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","volume":"99","author":"T Dekkers","year":"2014","unstructured":"Dekkers T, ter Meer M, Lenders JW, et al. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J Clin Endocrinol Metab. 2014;99(7):E1341\u20131351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7244_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/JU.0000000000001752","volume":"206","author":"ECJ van de Wiel","year":"2021","unstructured":"van de Wiel ECJ, Kusters B, Mann R, et al. Partial adrenalectomy carries a considerable risk of incomplete cure in primary aldosteronism. J Urol. 2021;206(2):219\u201328.","journal-title":"J Urol"},{"issue":"1","key":"7244_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC, et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol. 2022;33(1):155\u201396.","journal-title":"Endocr Pathol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07244-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07244-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07244-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:07:52Z","timestamp":1757149672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07244-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7244"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07244-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Human Research Ethics Committee of Fujian Medical University, and the informed consent was obtained from patients and volunteers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}